Titre : Oxidoreductases acting on sulfur group donors

Oxidoreductases acting on sulfur group donors : Questions médicales fréquentes

Termes MeSH sélectionnés :

Crop Protection
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Oxidoreductases acting on sulfur group donors : Questions médicales les plus fréquentes", "headline": "Oxidoreductases acting on sulfur group donors : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Oxidoreductases acting on sulfur group donors : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-16", "dateModified": "2025-04-10", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Oxidoreductases acting on sulfur group donors" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Oxidoreductases", "url": "https://questionsmedicales.fr/mesh/D010088", "about": { "@type": "MedicalCondition", "name": "Oxidoreductases", "code": { "@type": "MedicalCode", "code": "D010088", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.682" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Ferredoxine-NADP reductase", "alternateName": "Ferredoxin-NADP Reductase", "url": "https://questionsmedicales.fr/mesh/D005287", "about": { "@type": "MedicalCondition", "name": "Ferredoxine-NADP reductase", "code": { "@type": "MedicalCode", "code": "D005287", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.682.667.076" } } }, { "@type": "MedicalWebPage", "name": "Glutarédoxines", "alternateName": "Glutaredoxins", "url": "https://questionsmedicales.fr/mesh/D054477", "about": { "@type": "MedicalCondition", "name": "Glutarédoxines", "code": { "@type": "MedicalCode", "code": "D054477", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.682.667.084" } } }, { "@type": "MedicalWebPage", "name": "Glutathione reductase", "alternateName": "Glutathione Reductase", "url": "https://questionsmedicales.fr/mesh/D005980", "about": { "@type": "MedicalCondition", "name": "Glutathione reductase", "code": { "@type": "MedicalCode", "code": "D005980", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.682.667.092" } } }, { "@type": "MedicalWebPage", "name": "Hydrogensulfite reductase", "alternateName": "Hydrogensulfite Reductase", "url": "https://questionsmedicales.fr/mesh/D050885", "about": { "@type": "MedicalCondition", "name": "Hydrogensulfite reductase", "code": { "@type": "MedicalCode", "code": "D050885", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.682.667.124" } } }, { "@type": "MedicalWebPage", "name": "Protein-disulfide reductase (glutathione)", "alternateName": "Protein Disulfide Reductase (Glutathione)", "url": "https://questionsmedicales.fr/mesh/D011490", "about": { "@type": "MedicalCondition", "name": "Protein-disulfide reductase (glutathione)", "code": { "@type": "MedicalCode", "code": "D011490", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.682.667.186" } } }, { "@type": "MedicalWebPage", "name": "Sulfite dehydrogenase", "alternateName": "Sulfite Dehydrogenase", "url": "https://questionsmedicales.fr/mesh/D050902", "about": { "@type": "MedicalCondition", "name": "Sulfite dehydrogenase", "code": { "@type": "MedicalCode", "code": "D050902", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.682.667.217" } } }, { "@type": "MedicalWebPage", "name": "Sulfite oxidase", "alternateName": "Sulfite Oxidase", "url": "https://questionsmedicales.fr/mesh/D050876", "about": { "@type": "MedicalCondition", "name": "Sulfite oxidase", "code": { "@type": "MedicalCode", "code": "D050876", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.682.667.249" } } }, { "@type": "MedicalWebPage", "name": "Sulfite reductase (ferredoxin)", "alternateName": "Sulfite Reductase (Ferredoxin)", "url": "https://questionsmedicales.fr/mesh/D050889", "about": { "@type": "MedicalCondition", "name": "Sulfite reductase (ferredoxin)", "code": { "@type": "MedicalCode", "code": "D050889", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.682.667.374" } } }, { "@type": "MedicalWebPage", "name": "Sulfite reductase (NADPH)", "alternateName": "Sulfite Reductase (NADPH)", "url": "https://questionsmedicales.fr/mesh/D050864", "about": { "@type": "MedicalCondition", "name": "Sulfite reductase (NADPH)", "code": { "@type": "MedicalCode", "code": "D050864", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.682.667.500" } } }, { "@type": "MedicalWebPage", "name": "Thioredoxin reductase 1", "alternateName": "Thioredoxin Reductase 1", "url": "https://questionsmedicales.fr/mesh/D054481", "about": { "@type": "MedicalCondition", "name": "Thioredoxin reductase 1", "code": { "@type": "MedicalCode", "code": "D054481", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.682.667.750.500" } } }, { "@type": "MedicalWebPage", "name": "Thioredoxin reductase 2", "alternateName": "Thioredoxin Reductase 2", "url": "https://questionsmedicales.fr/mesh/D054482", "about": { "@type": "MedicalCondition", "name": "Thioredoxin reductase 2", "code": { "@type": "MedicalCode", "code": "D054482", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.682.667.750.750" } } } ], "about": { "@type": "MedicalCondition", "name": "Oxidoreductases acting on sulfur group donors", "alternateName": "Oxidoreductases Acting on Sulfur Group Donors", "code": { "@type": "MedicalCode", "code": "D050862", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Inês A C Pereira", "url": "https://questionsmedicales.fr/author/In%C3%AAs%20A%20C%20Pereira", "affiliation": { "@type": "Organization", "name": "Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras, Portugal." } }, { "@type": "Person", "name": "Shi Xu", "url": "https://questionsmedicales.fr/author/Shi%20Xu", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, Washington State University, Pullman, WA, 99164, USA." } }, { "@type": "Person", "name": "Ming Xian", "url": "https://questionsmedicales.fr/author/Ming%20Xian", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, Washington State University, Pullman, WA, 99164, USA." } }, { "@type": "Person", "name": "Wei Li", "url": "https://questionsmedicales.fr/author/Wei%20Li", "affiliation": { "@type": "Organization", "name": "School of Environmental Science and Engineering, Suzhou University of Science and Technology, Suzhou 215009, China; National and Local Joint Engineering Laboratory for Municipal Sewage Resource Utilization Technology, Suzhou University of Science and Technology, Suzhou 215009, China." } }, { "@type": "Person", "name": "Dorry L Segev", "url": "https://questionsmedicales.fr/author/Dorry%20L%20Segev", "affiliation": { "@type": "Organization", "name": "Department of Surgery, New York University Grossman School of Medicine, New York, NY." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Natural products in crop protection: thiosemicarbazone derivatives of 3-acetyl-N-benzylindoles as antifungal agents and their mechanism of action.", "datePublished": "2023-03-31", "url": "https://questionsmedicales.fr/article/36929618", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/ps.7457" } }, { "@type": "ScholarlyArticle", "name": "Discovery of rosin-based acylhydrazone derivatives as potential antifungal agents against rice Rhizoctonia solani for sustainable crop protection.", "datePublished": "2022-10-29", "url": "https://questionsmedicales.fr/article/36223125", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/ps.7232" } }, { "@type": "ScholarlyArticle", "name": "Eco-Oriented Formulation and Stabilization of Oil-Colloidal Biodelivery Systems Based on GC-MS/MS-Profiled Phytochemicals from Wild Tomato for Long-Term Retention and Penetration on Applied Surfaces for Effective Crop Protection.", "datePublished": "2023-02-20", "url": "https://questionsmedicales.fr/article/36802590", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1021/acs.jafc.2c08612" } }, { "@type": "ScholarlyArticle", "name": "Exogenous Application of dsRNA in Plant Protection: Efficiency, Safety Concerns and Risk Assessment.", "datePublished": "2024-06-13", "url": "https://questionsmedicales.fr/article/38928236", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijms25126530" } }, { "@type": "ScholarlyArticle", "name": "Oxime chemistry in crop protection.", "datePublished": "2024-05-28", "url": "https://questionsmedicales.fr/article/38804722", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/ps.8201" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Enzymes et coenzymes", "item": "https://questionsmedicales.fr/mesh/D045762" }, { "@type": "ListItem", "position": 3, "name": "Enzymes", "item": "https://questionsmedicales.fr/mesh/D004798" }, { "@type": "ListItem", "position": 4, "name": "Oxidoreductases", "item": "https://questionsmedicales.fr/mesh/D010088" }, { "@type": "ListItem", "position": 5, "name": "Oxidoreductases acting on sulfur group donors", "item": "https://questionsmedicales.fr/mesh/D050862" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Oxidoreductases acting on sulfur group donors - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Oxidoreductases acting on sulfur group donors", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-04-30", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Oxidoreductases acting on sulfur group donors", "description": "Comment diagnostiquer une déficience en oxydoréductases ?\nQuels tests sont utilisés pour évaluer l'activité des oxydoréductases ?\nLes tests génétiques sont-ils utiles pour le diagnostic ?\nQuels symptômes peuvent indiquer un problème enzymatique ?\nComment les analyses sanguines aident-elles au diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D050862?mesh_terms=Crop+Protection&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Oxidoreductases acting on sulfur group donors", "description": "Quels sont les symptômes d'une déficience en sulfure d'hydrogène ?\nComment se manifestent les troubles métaboliques liés aux oxydoréductases ?\nLes symptômes varient-ils selon le type d'oxydoréductase ?\nQuels signes cliniques sont associés aux maladies métaboliques ?\nLes troubles respiratoires peuvent-ils être liés aux oxydoréductases ?", "url": "https://questionsmedicales.fr/mesh/D050862?mesh_terms=Crop+Protection&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Oxidoreductases acting on sulfur group donors", "description": "Comment prévenir les maladies liées aux oxydoréductases ?\nLes dépistages précoces sont-ils recommandés ?\nL'éducation des patients est-elle importante ?\nLes vaccinations peuvent-elles jouer un rôle préventif ?\nComment le mode de vie influence-t-il la prévention ?", "url": "https://questionsmedicales.fr/mesh/D050862?mesh_terms=Crop+Protection&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Oxidoreductases acting on sulfur group donors", "description": "Quels traitements sont disponibles pour les déficiences enzymatiques ?\nLa thérapie génique est-elle une option pour ces maladies ?\nComment les médicaments peuvent-ils aider ?\nLes traitements sont-ils personnalisés selon le patient ?\nQuels rôles jouent les diététiciens dans le traitement ?", "url": "https://questionsmedicales.fr/mesh/D050862?mesh_terms=Crop+Protection&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Oxidoreductases acting on sulfur group donors", "description": "Quelles complications peuvent survenir avec ces déficiences ?\nLes complications sont-elles réversibles ?\nComment les complications affectent-elles la qualité de vie ?\nLes complications peuvent-elles être prévenues ?\nQuels sont les risques de complications à long terme ?", "url": "https://questionsmedicales.fr/mesh/D050862?mesh_terms=Crop+Protection&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Oxidoreductases acting on sulfur group donors", "description": "Quels sont les facteurs de risque pour les maladies métaboliques ?\nL'âge est-il un facteur de risque ?\nLe stress peut-il influencer ces maladies ?\nLes habitudes alimentaires jouent-elles un rôle ?\nLes facteurs environnementaux sont-ils significatifs ?", "url": "https://questionsmedicales.fr/mesh/D050862?mesh_terms=Crop+Protection&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une déficience en oxydoréductases ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests enzymatiques et des analyses biochimiques sont utilisés pour diagnostiquer." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer l'activité des oxydoréductases ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de spectrophotométrie et des dosages enzymatiques sont couramment utilisés." } }, { "@type": "Question", "name": "Les tests génétiques sont-ils utiles pour le diagnostic ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les tests génétiques peuvent identifier des mutations affectant les oxydoréductases." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer un problème enzymatique ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme la fatigue, des douleurs musculaires ou des troubles métaboliques peuvent survenir." } }, { "@type": "Question", "name": "Comment les analyses sanguines aident-elles au diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Les analyses sanguines mesurent les niveaux de métabolites et d'enzymes spécifiques." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une déficience en sulfure d'hydrogène ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des troubles neurologiques, des douleurs abdominales et des nausées." } }, { "@type": "Question", "name": "Comment se manifestent les troubles métaboliques liés aux oxydoréductases ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent se manifester par des déséquilibres électrolytiques et des anomalies de croissance." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon le type d'oxydoréductase ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent varier en fonction de l'enzyme spécifique impliquée." } }, { "@type": "Question", "name": "Quels signes cliniques sont associés aux maladies métaboliques ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des signes comme l'hyperlipidémie, l'hyperglycémie et des anomalies hépatiques peuvent apparaître." } }, { "@type": "Question", "name": "Les troubles respiratoires peuvent-ils être liés aux oxydoréductases ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains troubles respiratoires peuvent être causés par des déséquilibres métaboliques." } }, { "@type": "Question", "name": "Comment prévenir les maladies liées aux oxydoréductases ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée et des bilans de santé réguliers peuvent aider à prévenir ces maladies." } }, { "@type": "Question", "name": "Les dépistages précoces sont-ils recommandés ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des dépistages précoces peuvent identifier des anomalies enzymatiques avant l'apparition des symptômes." } }, { "@type": "Question", "name": "L'éducation des patients est-elle importante ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, informer les patients sur les signes et symptômes peut aider à une détection rapide." } }, { "@type": "Question", "name": "Les vaccinations peuvent-elles jouer un rôle préventif ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Certaines vaccinations peuvent prévenir des infections qui aggravent les troubles métaboliques." } }, { "@type": "Question", "name": "Comment le mode de vie influence-t-il la prévention ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Un mode de vie sain, incluant exercice et nutrition, peut réduire le risque de maladies métaboliques." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour les déficiences enzymatiques ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des suppléments enzymatiques et des modifications diététiques." } }, { "@type": "Question", "name": "La thérapie génique est-elle une option pour ces maladies ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la thérapie génique est explorée comme une option pour corriger des déficiences spécifiques." } }, { "@type": "Question", "name": "Comment les médicaments peuvent-ils aider ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Certains médicaments peuvent aider à réguler les niveaux de métabolites et à soulager les symptômes." } }, { "@type": "Question", "name": "Les traitements sont-ils personnalisés selon le patient ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traitements sont souvent adaptés en fonction des besoins individuels du patient." } }, { "@type": "Question", "name": "Quels rôles jouent les diététiciens dans le traitement ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Les diététiciens aident à concevoir des régimes alimentaires adaptés aux besoins métaboliques." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec ces déficiences ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications comme des troubles neurologiques, des maladies cardiovasculaires peuvent survenir." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être réversibles avec un traitement approprié, d'autres non." } }, { "@type": "Question", "name": "Comment les complications affectent-elles la qualité de vie ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent réduire la qualité de vie en limitant les activités quotidiennes et en causant de la douleur." } }, { "@type": "Question", "name": "Les complications peuvent-elles être prévenues ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une gestion proactive des symptômes et un suivi médical régulier peuvent aider." } }, { "@type": "Question", "name": "Quels sont les risques de complications à long terme ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les risques incluent des maladies chroniques et des défaillances organiques si non traitées." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour les maladies métaboliques ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des antécédents familiaux, une mauvaise alimentation et le manque d'exercice." } }, { "@type": "Question", "name": "L'âge est-il un facteur de risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'âge avancé peut augmenter le risque de développer des troubles métaboliques." } }, { "@type": "Question", "name": "Le stress peut-il influencer ces maladies ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut aggraver les symptômes et augmenter le risque de complications." } }, { "@type": "Question", "name": "Les habitudes alimentaires jouent-elles un rôle ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation riche en graisses et en sucres peut augmenter le risque de maladies." } }, { "@type": "Question", "name": "Les facteurs environnementaux sont-ils significatifs ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition à des toxines environnementales peut affecter l'activité des oxydoréductases." } } ] } ] }

Sources (10000 au total)

Natural products in crop protection: thiosemicarbazone derivatives of 3-acetyl-N-benzylindoles as antifungal agents and their mechanism of action.

Phytopathogenic fungi can cause a direct loss in economic value of agriculture. Especially Valsa mali Miyabe et Yamada, a devastating phytopathogenic disease especially threatening global apple produc... Derivatives displayed potent antifungal activity against V. mali. Notably, 3-acetyl-N-benzylindole thiosemicarbazone (IV-1: EC... 3-Acetyl-N-(un)substituted benzylindoles thiosemicarbazones (IV-1-IV-5) can be studied as leads for further structural modification as antifungal agents against V. mali. Particularly, these ergosterol...

Discovery of rosin-based acylhydrazone derivatives as potential antifungal agents against rice Rhizoctonia solani for sustainable crop protection.

The use of fungicides to protect crops from diseases is an effective method, and novel environmentally friendly plant-derived fungicides with enhanced performance and low toxicity are urgent requireme... Two kinds of rosin-based acylhydrazone compounds were designed and prepared. Based on the antifungal activity assessment against Rhizoctonia solani, Fusarium oxysporum, Phytophthora capsici, Sclerotin... This study provides a basis for exploiting potential rosin-based fungicides in promoting sustainable crop protection. © 2022 Society of Chemical Industry....

Eco-Oriented Formulation and Stabilization of Oil-Colloidal Biodelivery Systems Based on GC-MS/MS-Profiled Phytochemicals from Wild Tomato for Long-Term Retention and Penetration on Applied Surfaces for Effective Crop Protection.

Vegetable oils as hydrophobic reserves in oil dispersions (OD) provide a practical approach to halt bioactive degradation for user and environment-efficient pest management. Using biodegradable soybea...